Literature DB >> 31982369

Dose reduction in head and neck organs through shielding and application of different scanning parameters in cone beam computed tomography: an effective dose study using an adult male anthropomorphic phantom.

Diana Attaia1, Stephanie Ting2, Brandon Johnson3, Mohamed I Masoud2, Bernard Friedland2, Mona Abu El Fotouh4, Shaimaa Abu El Sadat4.   

Abstract

OBJECTIVES: The aim of this study was to determine the effect of shielding and scanning parameters on radiation dose reduction to the organs in the head and neck region in cone beam computed tomography (CBCT). STUDY
DESIGN: An anthropomorphic phantom and optically stimulated luminescent dosimeters were used to calculate the changes in effective or equivalent doses to 9 anatomic structures through the addition of a thyroid collar, radiation safety glasses, and a radiation safety cap and by using different scanning protocols on a CS 9300 CBCT unit.
RESULTS: The thyroid collar alone yielded dose reductions of 46% to the thyroid gland and at least 38% to the esophagus, but no more than 12% to the salivary glands. The radiation safety cap significantly reduced doses to the brain and the pituitary gland. Full shielding resulted in dose reductions of at least 50% to the thyroid gland, at least 47% to the esophagus, and approximately 35% to the brain and the pituitary gland. Significant dose reductions were recorded for all tissues with the "low dose" setting compared with the standard setting.
CONCLUSIONS: Increased protection of the organs in the head and neck regions can be achieved by using various forms of shielding in CBCT imaging, with selection of the most appropriate scanning parameters based on the purpose of the examination.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31982369     DOI: 10.1016/j.oooo.2019.11.012

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  1 in total

1.  Computed tomography-guided cutting needle biopsy for lung nodules: A comparative study between low-dose and standard dose protocols.

Authors:  Hui-Mei Zhang; Xiao-Bing Huo; Hua-Long Wang; Xiao Zhang; Yu-Fei Fu
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.